MedPath

Ayurvedic management of hyperactive children

Phase 2
Not yet recruiting
Conditions
Attention-deficit hyperactivity disorder, combined type,
Registration Number
CTRI/2022/07/044380
Lead Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Brief Summary

The objective of the study is to clinically evaluate the effectiveness of Saraswatha choorna along with Abhyanga, Parisheka and Shirodhara in Attention deficit hyperactivity disorder (ADHD) in children. 20 subjects diagnosed with ADHD will be administered with Saraswatha choorna internally and Abhyanga and Shirodhara with Murchita tila taila and Parisheka with Balamoola Kashaya. Abhyanaga, Parisheka and Shirodhara will be done for first seven days and last seven days with a gap of 16 days. The assessment was made using Conners Parent Rating Scale.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Children of the age group of 3-8years irrespective of gender, religion, socioeconomic status and fulfilling the diagnostic criteria.
  • The children whose parents are willing to participate in the study and ready to sign the consent form.
Exclusion Criteria
  • Children with other CNS manifestations like Cerebral palsy with hyperkinetic disorder, history of brain damage and other syndromes affecting CNS.
  • Children with impaired vision/ impaired hearing.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in CONNERS PARENT RATING SCALE REVISED (CPRS-R)1st and 30th day
Secondary Outcome Measures
NameTimeMethod
Changes in CONNERS PARENT RATING SCALE REVISED (CPRS-R)8th and 22th day

Trial Locations

Locations (1)

SDM College of Ayurveda and Hospital

🇮🇳

Hassan, KARNATAKA, India

SDM College of Ayurveda and Hospital
🇮🇳Hassan, KARNATAKA, India
Dr Vandana Lakshmi
Principal investigator
9496200821
vandanalakshmi1710@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.